Znn3bq.jpeg
²é¿´: 301  |  »Ø¸´: 2

liruihan

Ìú¸Ëľ³æ (ÕýʽдÊÖ)


[×ÊÔ´] ¡¾×ÊÔ´¡¿Cancer: Predictions in lymphoma

The presence of a specific cell type in people with lymphoma is negatively associated with survival, providing a new biomarker with potential clinical applications (Proc. Natl. Acad. Sci. USA 107, 12747¨C12754).
Jonathan Irish et al. used single-cell profiling in samples of human follicular lymphoma and found a subset of lymphoma cells with defective B cell antigen receptor (BCR) signaling. Jonathan Irish The more of these cells in each tumor, the shorter the overall subject survival. Moreover, these lymphoma cells increased in number as tumors relapsed after chemotherapy. Interestingly, BCR signaling could be reactivated in the defective cells, indicating that BCR signaling was not altogether absent but somehow suppressed.
Mechanistically, tumors with high counts of defective BCR cells had less interleukin-7 signaling in infiltrating T cells, but additional work will be required to understand how these cells emerge and what their downstream effects are.
In addition to representing a potential biomarker, the existence of cells with defective BCR signaling may provide new targets against follicular lymphoma.¡ªJCL
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

liruihan

Ìú¸Ëľ³æ (ÕýʽдÊÖ)


°©Ö¢£ºÁܰÍÁöÖеÄÔ¤²âÒò×Ó
ÁܰÍÁö²¡ÈËÖÐÌØÒìϸ°ûÀàÐ͵ĴæÔÚÓ벡È˵ÄÉú´æ³Ê¸ºÏà¹Ø£¬¸Ã·¢ÏÖ¿ÉÌṩһÖÖеÄÉúÎï±ê¼ÇÎ²¢¾ßÓÐDZÔÚµÄÁÙ´²ÒâÒå¡£
ÔÚÂËÅÝÐÔÁܰÍÁöÑù±¾ÖÐʹÓõ¥Ï¸°û·ÂÐÎÇÐÏ÷¼¼Êõ·¢ÏÖÁËһЩ¾ßÓÐȱÏÝBϸ°û¿¹Ô­ÊÜÌ壨BCR£©ÐźŵÄÁܰÍÁöϸ°û¡£Ã¿¸öÖ×ÁöÖÐÕâЩϸ°ûÔ½¶à£¬²¡È˵ÄÉú´æÆÚÔ½¶Ì¡£¶øÇÒ£¬µ±»¯ÁƺóÖ×Áö¸´·¢Ê±ÕâЩÁܰÍÁöϸ°ûÊýÁ¿ÉÏÔö¼Ó¡£ÁîÈ˸ÐÐËȤµÄÊÇ£¬ÔÚÕâЩȱÏÝϸ°ûÖÐBCRÐźſÉÄÜÖØÐ»£¬ÌáʾBCRÐźŲ»ÊÇÒ»Æðȱ·¦¶øÊÇÓÐЩ±»ÒÖÖÆÁË¡£
»úÖÆÉÏ£¬°éÓнϸßÊýÁ¿È±ÏÝBCRµÄÖ×ÁöÔÚ½þÈóµÄTϸ°ûÖнÏÉÙ±í´ïIL-7Ðźţ¬µ«ÐèÒªÁíÍâµÄ¹¤×÷À´Àí½âÕâЩϸ°ûÊÇÈçºÎ³öÏֵĺÍËüÃǵÄÏÂÓÎЧӦÊÇʲô¡£
³ýÁË´ú±íDZÔÚµÄÉúÎï±ê¼ÇÎïÍ⣬°éÓÐȱÏÝBCRÐźŵÄϸ°û´æÔÚ¿ÉÌṩÂËÅÝÐÔÁܰÍÁöеİе㡣
2Â¥2010-09-14 16:35:17
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lrj107hn

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)


ÕâÊÇÄÄÀïµÄ×ÊÔ´£¿
3Â¥2010-09-14 18:17:29
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ liruihan µÄÖ÷Ìâ¸üÐÂ
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 297Çóµ÷¼Á +18 ORCHID1 2026-04-10 19/950 2026-04-13 09:21 by lhj2009
[¿¼ÑÐ] »¯Ñ§070300 Çóµ÷¼Á +17 ¹þ¹þ¹þ^_^ 2026-04-12 17/850 2026-04-13 08:59 by ×ÏêØ×ÏÆå
[¿¼ÑÐ] ²ÄÁϹ¤³Ì085601£¬270Çóµ÷¼Á +36 @ASDF1234 2026-04-08 39/1950 2026-04-13 08:37 by Delta2012
[¿¼ÑÐ] µçÆø¹¤³Ìר˶320Çóµ÷¼Á +5 СÂé×Ó111 2026-04-10 5/250 2026-04-12 10:47 by zhouyuwinner
[¿¼ÑÐ] 313Çóµ÷¼Á +5 Óà°Ú°ÚÊÇ´ó¸ç 2026-04-11 5/250 2026-04-12 10:34 by Öí»á·É
[¿¼ÑÐ] 308Çóµ÷¼Á +5 VvvvL 2026-04-10 5/250 2026-04-12 10:17 by babysonlkd
[¿¼ÑÐ] Çóµ÷¼Á£¬262»úеר˶ +8 àÅyyl 2026-04-08 8/400 2026-04-12 02:31 by Çï¶¹²ËÑ¿
[ÕÒ¹¤×÷] ɽ¶«¸ßУ½Ìʦ¿¼ºË³¬¼¶ÎÞµ×Ïߣ¬Ô±¹¤¹ý²»ÏÂÈ¥À² +4 qut2026 2026-04-09 9/450 2026-04-12 00:54 by qut2026
[¿¼ÑÐ] 284Çóµ÷¼Á +11 archer.. 2026-04-09 12/600 2026-04-11 20:23 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 283Çóµ÷¼Á 086004¿¼Ó¢¶þÊý¶þ +17 ÄǸöàà×Ó 2026-04-10 18/900 2026-04-11 16:27 by Ã÷Ô´ËʱÓÐ
[¿¼ÑÐ] 087100³õÊÔ311Çóµ÷¼Á +4 ÈÎÑÅÇÙ 2026-04-09 4/200 2026-04-11 10:33 by zhq0425
[¿¼ÑÐ] 346£¬¹¤¿Æ0854Çóµ÷¼Á£¬×¨Ë¶ +7 moser233 2026-04-10 8/400 2026-04-11 08:52 by Öí»á·É
[¿¼ÑÐ] µ÷¼Á +12 ¾í¾í¾íÐIJË_ 2026-04-09 13/650 2026-04-10 22:36 by Ftglcn90
[¿¼ÑÐ] ¿¼Ñе÷¼Á-²ÄÁÏÀà-284 +28 Ïë»»ÊÖ»ú²»Ïë½âÊ 2026-04-08 28/1400 2026-04-09 20:08 by µ¹Êý321?
[¿¼ÑÐ] µ÷¼Á +19 2261744733 2026-04-08 19/950 2026-04-09 19:11 by vgtyfty
[¿¼ÑÐ] 337Çóµ÷¼Á +4 Gky09300550£¬ 2026-04-09 4/200 2026-04-09 17:18 by ÅÁ¶ûÂíÀ­ÌØ
[¿¼ÑÐ] Çóµ÷¼Á²ÄÁÏ¿ÆÑ§Ó빤³ÌÒ»Ö¾Ô¸985³õÊÔ365·Ö +5 ²Ä»¯Àî¿É 2026-04-08 5/250 2026-04-09 17:00 by Lilly_Li
[¿¼ÑÐ] 1U¶Ü¼ÇµÃ¼ÇµÃ¾Í +9 sanjin020722 2026-04-08 10/500 2026-04-09 14:11 by Ê«Óë×ÔÓÉ
[¿¼ÑÐ] 22408 һ־Ը˫һÁ÷È˹¤ÖÇÄÜ300·Ö ËÄÁù¼¶£¬Êý¾Ý·ÖÎö¹ú½± +4 zzfeng123 2026-04-06 6/300 2026-04-07 21:02 by zzfeng123
[¿¼ÑÐ] 325 µ÷¼Á +6 QQСϺ 2026-04-07 6/300 2026-04-07 15:17 by Ccclqqq
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û